These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26412358)

  • 21. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
    Luo MX; Hua S; Shang QY
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
    Gupta U; Jain NK
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanotechnology approaches for inhalation treatment of lung diseases.
    Kuzmov A; Minko T
    J Control Release; 2015 Dec; 219():500-518. PubMed ID: 26297206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of nanotechnology-based formulations in pediatric populations.
    Yellepeddi VK; Joseph A; Nance E
    Adv Drug Deliv Rev; 2019; 151-152():44-55. PubMed ID: 31494124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies.
    Kaye RS; Purewal TS; Alpar HO
    J Pharm Sci; 2009 Nov; 98(11):4055-68. PubMed ID: 19189420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein and peptide delivery to lungs by using advanced targeted drug delivery.
    Chellappan DK; Prasher P; Saravanan V; Vern Yee VS; Wen Chi WC; Wong JW; Wong JK; Wong JT; Wan W; Chellian J; Molugulu N; Prabu SL; Ibrahim R; Darmarajan T; Candasamy M; Singh PK; Mishra V; Shastri MD; Zacconi FC; Chakraborty A; Mehta M; Gupta PK; Dureja H; Gulati M; Singh SK; Gupta G; Jha NK; George Oliver BG; Dua K
    Chem Biol Interact; 2022 Jan; 351():109706. PubMed ID: 34662570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovative formulations for controlled drug delivery to the lungs and the technical and toxicological challenges to overcome(.).
    Aragao-Santiago L; Bohr A; Delaval M; Dalla-Bona AC; Gessler T; Seeger W; Beck-Broichsitter M
    Curr Pharm Des; 2016; 22(9):1147-60. PubMed ID: 26675224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in Sub-Micron Particle Based Aerosol Strategies for Efficient Systemic Delivery of Therapeutic Agents.
    Joshi N; Kaur S; Banerjee R
    Curr Pharm Des; 2016; 22(17):2470-80. PubMed ID: 26915832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges.
    Ruge CA; Kirch J; Lehr CM
    Lancet Respir Med; 2013 Jul; 1(5):402-13. PubMed ID: 24429205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of different vitamin E carriers intended for pulmonary drug delivery.
    Laouini A; Andrieu V; Vecellio L; Fessi H; Charcosset C
    Int J Pharm; 2014 Aug; 471(1-2):385-90. PubMed ID: 24939617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivalency in Drug Delivery-When Is It Too Much of a Good Thing?
    Tjandra KC; Thordarson P
    Bioconjug Chem; 2019 Mar; 30(3):503-514. PubMed ID: 30742420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
    Nasr M; Najlah M; D'Emanuele A; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled pulmonary drug and gene delivery using polymeric nano-carriers.
    Beck-Broichsitter M; Merkel OM; Kissel T
    J Control Release; 2012 Jul; 161(2):214-24. PubMed ID: 22192571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic systems in drug delivery applications.
    Jain NK; Asthana A
    Expert Opin Drug Deliv; 2007 Sep; 4(5):495-512. PubMed ID: 17880273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nano-formulations of drugs: Recent developments, impact and challenges.
    Jeevanandam J; Chan YS; Danquah MK
    Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biokinetics of Aerosolized Liposomal Ciclosporin A in Human Lung Cells In Vitro Using an Air-Liquid Cell Interface Exposure System.
    Schmid O; Jud C; Umehara Y; Mueller D; Bucholski A; Gruber F; Denk O; Egle R; Petri-Fink A; Rothen-Rutishauser B
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):411-424. PubMed ID: 28683218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendrimers and the development of new complex nanomaterials for biomedical applications.
    Gardikis K; Micha-Screttas M; Demetzos C; Steele BR
    Curr Med Chem; 2012; 19(29):4913-28. PubMed ID: 22963629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in pulmonary delivery of nanoparticles.
    Kaur G; Narang RK; Rath G; Goyal AK
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):75-96. PubMed ID: 21806501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotechnology and pharmaceutical inhalation aerosols.
    Patel AR; Vavia PR
    Indian J Exp Biol; 2007 Feb; 45(2):166-74. PubMed ID: 17375556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.